Key facts
- This page summarizes Kyle Piskel's Form 4 filing for Adaptive Biotechnologies Corp (ADPT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 May 2026, 19:13.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Additional SEC filing notes
Footnote F1
This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.